The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.25
Bid: 26.00
Ask: 26.50
Change: -4.25 (-13.93%)
Spread: 0.50 (1.923%)
Open: 30.50
High: 30.50
Low: 25.75
Prev. Close: 30.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: ING Real, Intellego, Oxford Intruments...

Wed, 20th Jan 2010 13:10

ING UK Real Estate Income Trust will repay £15m of debt through the purchase and cancellation of loan notes at a discount to nominal value in two separate transactions.The transaction will result in a one off gain to NAV expected to be in the order of £680,000, and will also save over £719,000 per annum in interest charges."This is an opportunistic purchase, enabling us to enhance both the underlying NAV and income account, whilst de-risking the overall portfolio by maintaining the current LTV ratio and improving the interest cover position, fund manager Michael Morris said.Angus Forrest, training and e-learning group Intellego's chairman, says the firm has won a material order with a leading retail specialist to provide productivity improvement services for the next 12 months. Order intake in the third quarter of the year ending 31 March 2010 was £898,000.Oxford Instruments performance from October to January was in line with the board's expectations and above the same period in the prior year, aided by the effects of the restructuring programme implemented last year and favourable currency movements. Research markets remain robust. The tentative signs of improvement in Industrial markets continue, albeit from a low level and visibility remains limited, it added.Lower than expected endoscopy sales and higher field costs will mean Puricore's earnings this year missing targets, though it says the miss will not be significant. Fourth quarter sales in 2009 were $10.4m, up 75%, while revenue for the year was about $40m, up 19%. "In 2010, the company anticipates cash flow profitability in PuriCore's Endoscopy business in the UK and continued significant progress in the Food Safety business in both the US and Canada," it said. Cake and bread maker Finsbury Food Group has appointed Stephen Boyd as its new finance boss and confirmed it continues to trade in line with market expectations.The 47-year-old, who has experience at WT Foods, Noon Products and Golden Wonder, replaces Lisa Morgan who'll leave the company by the end of March 2010.Renewable fuels company GTL Resources had a record December, with subsidiary Illinois River Energy selling 9.8 million gallons of ethanol and 24.2 thousand tons of dried distillers grains with solubles.'With the recent commodity margin rally in the ethanol industry coupled with GTL's strong operational performance since September 2009, the group expects to report improved results in the second half,' said the firm.Asset finance company 1pm said trading has been in line with management expectations since its last trading update in October. Revenue in the 6 months to 30 November 2009 edged higher to £0.68m from £0.66m the year before, but the loss before tax widened to £0.23m from £0.01m.Bad debt write-offs in the period were £95,000, while general bad debt provisions of £120,000 were accrued as a result of a number of customers going bankrupt during the reporting period.Brulines, which provides monitoring systems and data management services for the UK leisure sector, has won a contract to supply vending telemetry hardware over a period of three years to an unnamed international consumer goods company.Chinese specialist engineering company China Wonder has taken a £0.2m loan from Wonder Employees Capital Limited (WECL), a company wholly owned by Qingjie Zhao, a substantial shareholder.The loan accrues interest at a rate of 5% per annum. The loan agreement gives WECL the right to convert the loan into ordinary shares in the capital of China Wonder at a price of 10p per share. Scientists at the Institute of Cancer Research and Sareum have developed a chemical compounds that increase the effectiveness of current cancer therapeutics.Media services business Dawson Holdings is on the look-out for a new finance director after the current position holder, Adrian Wood, announced his intention to retire from the role on 31 March. Wood will stay on as company secretary until the end of June.
More News
19 Apr 2024 12:16

IN BRIEF: Sareum falls as issues shares to RiverFort Global

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company - Issues 3.0 million new shares in the company to RiverFort Global Opportunities PCC Ltd. Issue is in line with facility announced in August. Says facility has an outstanding balance of GBP220,000.

Read more
4 Apr 2024 17:24

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Apr 2024 17:35

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Mar 2024 13:44

EARNINGS AND TRADING: Northamber loss widens; Ethernity contract boost

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Mar 2024 13:11

Sareum allowed European patent for primary kinase inhibitor asset

(Sharecast News) - Biotechnology company Sareum announced on Friday that the European Patent Office had issued a notice of allowance for a patent concerning SDC‐1801, its primary TYK2/JAK1 kinase inhibitor currently undergoing clinical trials in Australia.

Read more
15 Mar 2024 12:46

Sareum Holdings touts new patent allowance for autoimmune therapy

(Alliance News) - Sareum Holdings PLC on Friday celebrated a new patent allowance for SDC-1801, which is a therapy designed to treat a range of autoimmune diseases.

Read more
12 Mar 2024 15:23

Sareum shares slump on widened loss and funding talks

(Alliance News) - Sareum Holdings PLC share fell on Tuesday, after it said it expects to report a widened interim loss.

Read more
15 Feb 2024 13:22

Sareum reports positive progress in psoriasis programme

(Sharecast News) - Sareum announced significant milestones in its phase 1a clinical trial for SDC-1801, its lead programme aimed at addressing autoimmune diseases such as psoriasis, on Thursday.

Read more
15 Feb 2024 11:20

Sareum hails safety profile for SDC-1801 after phase 1 trial

(Alliance News) - Sareum Holdings PLC on Thursday said SDC-1801 has the potential to achieve therapeutically effective dose levels with no serious adverse events, following a phase 1 trial.

Read more
15 Feb 2024 10:52

AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
2 Jan 2024 13:54

Sareum shares jump on cancer drug licensing deal

(Sharecast News) - Shares in AIM-listed biotech group Sareum jumped by a fifth on Tuesday after its co-development partner for cancer treatment SRA737 signed a commercialisation licence agreement with a US biopharma company.

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 10:05

AIM WINNERS & LOSERS: LungLife AI soars on test; Plexus falls on deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
2 Jan 2024 09:31

Sareum soars as partner agrees SRA737 licence with US biopharma firm

(Alliance News) - Sareum Holdings PLC shares surged on Tuesday, after it said its co-development partner CRT Pioneer Fund entered into a development and commercialisation licence for SRA737 with an unnamed US biopharmaceutical company.

Read more
14 Dec 2023 20:20

EARNINGS AND TRADING: CleanTech raises GBP520,000 in open offer

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.